DEA Adds Metonitazene to Schedule I Drug List
The Drug Enforcement Administration permanently placed the synthetic benzimidazol-opioid metonitazene on Schedule I of the Controlled Substances Act, it said in a final order released Aug. 17. The substance had already been temporarily listed in Schedule I since 2022 (see…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
2204110029). The final order is set to take effect Sept. 18.